RUNX Proteins as Epigenetic Modulators in Cancer

Area of Science:

• * Molecular Biology
• * Developmental Biology
• * Cancer Research

Background:

• * RUNX proteins are conserved transcription factors essential for metazoan development.
• * Aberrant RUNX protein function is implicated in diverse cancer types.
• * RUNX proteins interact with key signaling pathways (Wnt, TGF-β, Hippo) in tumorigenesis.

Purpose of the Study:

• * To review the multifaceted roles of RUNX proteins in cancer development and progression.
• * To elucidate the regulatory mechanisms and functions of RUNX proteins across different cancer types.
• * To highlight the emerging role of RUNX proteins as epigenetic modulators in oncology.

Main Methods:

• * Comprehensive literature review of studies on RUNX proteins in cancer.
• * Analysis of molecular mechanisms, including transcriptional regulation and TF interactions.
• * Examination of RUNX protein involvement in signaling pathways and chromatin modulation.

Main Results:

• * RUNX proteins exhibit context-specific functions in different cancers.
• * They act as transcription factors and interact with other TFs to influence gene expression.
• * RUNX proteins modulate chromatin architecture, impacting tumorigenesis.
• * Cross-talk with Wnt, TGF-β, and Hippo pathways is critical for their oncogenic functions.

Conclusions:

• * RUNX proteins are key regulators in cancer, with diverse roles depending on the tumor type.
• * Their functions as transcription factors and epigenetic modulators present therapeutic opportunities.
• * Further research into RUNX protein regulation and interactions is warranted for targeted cancer therapies.